North American Reishi

Metadata

Regulatory Status

United States

• Dietary supplement: G. sessile is not specifically recognized or regulated. However, it is present in US commercial reishi products marketed under DSHEA. Wu et al. (2017) and Loyd et al. (2018) demonstrated through ITS sequencing that many US “reishi” supplements and grow-your-own kits labeled as G. lucidum actually contain G. sessile or other North American Ganoderma species.
• FDA GRAS: No GRAS determination for G. sessile specifically.
• Wild harvest: Commonly wild-harvested by mushroom foragers in eastern North America for personal medicinal use.

European Union

• Not recognized: G. sessile is not a native European species and has no regulatory standing in the EU.

China / East Asia

• Not used in TCM: G. sessile is not part of the Chinese, Korean, or Japanese medicinal traditions, which use G. lingzhi (Chinese lingzhi), G. lucidum (European), or related East Asian species.

Western Integrative Medicine

• G. sessile is increasingly recognized by North American herbalists and integrative practitioners as a native alternative to imported Asian reishi. However, formal clinical validation is absent, and use is based on genus-level pharmacological inference and traditional knowledge of laccate Ganoderma species.

Conditions & Indications

Note: All indications below are inferred from the extensively studied Ganoderma genus, particularly G. lingzhi and G. lucidum. No clinical trials have been conducted specifically on G. sessile.

Primary Indications (Inferred from Genus)

• Immune modulation — The Ganoderma genus is defined by beta-glucan polysaccharides that activate innate immunity via Dectin-1 and CR3 receptors. G. sessile is expected to share this core immunomodulatory mechanism based on phylogenetic proximity and confirmed triterpenoid production.
• Antioxidant activity — Ganoderma species broadly demonstrate significant antioxidant capacity through polysaccharides, triterpenoids, and phenolic compounds. This activity is expected in G. sessile extracts.

Secondary Indications (Inferred from Genus)

• Anti-inflammatory effects — Ganoderic acids across Ganoderma species inhibit NF-kB signaling and suppress COX-2 expression.
• Adaptogenic stress support — Ganoderma species are traditionally used as adaptogens across multiple cultural traditions, though G. sessile has no specific traditional use history.

Emerging/Preclinical Indications

• Biotransformation of exogenous terpenes — Li et al. (2023) demonstrated that G. sessile mycelial cultures can biotransform the exogenous diterpene dihydrotanshinone I (DHT, from Salvia miltiorrhiza) into ganoderic acid analogs, including two novel lanostane-type compounds (LTHA and LTCA). This suggests unique biosynthetic capabilities that may yield novel pharmacologically active triterpenoids not found in other Ganoderma species.
• Antimicrobial potential — Ganoderma species demonstrate broad antimicrobial effects by disrupting bacterial cell walls and membranes. Species-specific antimicrobial studies on G. sessile are needed.

Mechanism of Action

Primary Mechanisms (Inferred from Genus)

1. Beta-glucan innate immune activation Like other Ganoderma species, G. sessile is expected to contain beta-1,3/1,6-D-glucan polysaccharides that bind pattern recognition receptors (Dectin-1 and CR3) on innate immune cells. This triggers NF-kB and MAPK signaling cascades, enhancing phagocytosis, cytokine production, and NK cell cytotoxicity.

2. Triterpenoid pharmacology (confirmed) Li et al. (2023) confirmed that G. sessile mycelial cultures produce ganoderic acid-type triterpenoids, including novel lanostane derivatives. The study demonstrated biotransformation of exogenous diterpene 15,16-dihydrotanshinone I into:

• Lanosta-7,9(11),24-trien-15alpha,22beta-diacetoxy-3beta-hydroxy-26-oic acid (LTHA)
• Lanosta-7,9(11),24-trien-15alpha,22beta-diacetoxy-3beta-carbonyl-26-oic acid (LTCA)

These compounds were characterized by HR-ESI-MS and NMR spectrometry and confirmed through transcriptome and proteome analysis. This study provides direct evidence that G. sessile possesses the enzymatic machinery for lanostane-type triterpenoid biosynthesis.

3. Adenosine-mediated effects (inferred) Ganoderma species characteristically contain adenosine, which contributes to sedative and antiplatelet activities via A1 and A2A receptor activation.

Secondary Mechanisms

• Ergosterol content: Expected provitamin D2 precursor activity
• Polyphenolic compounds: Antioxidant free radical scavenging

Comparison with Other North American Ganoderma Species

Clinical Evidence Summary

Species-Specific Studies

Evidence Limitations

• No clinical trials exist for molecularly verified G. sessile material. This is the most significant limitation.
• The only species-specific pharmacological study (Li et al. 2023) is a biotransformation study, not a bioactivity assessment.
• All bioactivity claims are inferred from the broader Ganoderma genus. The degree to which G. sessile shares the specific bioactive profile and potency of G. lingzhi or G. lucidum is unknown.
• The triterpenoid profile of G. sessile fruiting bodies has not been comprehensively characterized, and may differ significantly from East Asian species.
• Wild-harvested G. sessile specimens vary considerably in chemical composition depending on host tree, geographic location, and maturity.
• The presence of G. sessile in commercial reishi products marketed as G. lucidum represents an unresolved quality control and labeling issue in the supplement industry.

Safety Profile

General Assessment

No species-specific safety data exist for G. sessile. Safety assessment is entirely inferred from the Ganoderma genus. Ganoderma species have been consumed medicinally for millennia with a generally favorable safety profile. However, the specific safety characteristics of G. sessile, including any species-unique toxicological properties, are unknown.

Contraindications (Inferred from Genus)

• Autoimmune disease: Immunostimulatory beta-glucan activity may theoretically exacerbate autoimmune conditions.
• Bleeding disorders: Antiplatelet activity (via adenosine) is characteristic of Ganoderma species.
• Pre-surgical: Discontinue at least 2 weeks before scheduled surgery (precautionary).
• Pregnancy and lactation: No safety data of any kind. Avoid.

Drug Interactions (Inferred from Genus)

• Anticoagulants/antiplatelets: Potential increased bleeding risk. Severity: Unknown; precautionary moderate.
• Immunosuppressants: Potential immunostimulatory antagonism. Severity: Unknown; precautionary moderate.
• CYP450 substrates: Ganoderma triterpenoids may inhibit CYP enzymes. Severity: Unknown.

Side Effects

• No species-specific adverse event reports exist for G. sessile.
• Based on genus: gastrointestinal upset, dry mouth, and mild dizziness are possible.

Clinical Dosage

No species-specific dosage guidelines exist for G. sessile. The following are extrapolated from Ganoderma genus dosing conventions.

Dried Fruiting Body

• Inferred dose: 3-9 g/day as decoction (based on genus dosing)
• Preparation: Sliced and simmered 1-2 hours to extract polysaccharides

Dual-Extract Tincture

• Inferred dose: 2-4 mL of 1:5 dual-extract (hot water + ethanol), two to three times daily
• Captures both polysaccharides and triterpenoids

Wild-Harvested Material

• Caution: Wild G. sessile varies significantly in chemical composition. Species identification should be confirmed before medicinal use.
• Note: G. sessile can superficially resemble Ganoderma applanatum (Artist’s Conk), which has a different medicinal profile. Proper identification requires examination of the laccate (glossy, varnished) upper surface characteristic of G. sessile.

Sources

• Murrill WA. The Polyporaceae of North America. I. The genus Ganoderma. Bull Torrey Bot Club. 1902;29(10):599-608
• Li YH, Yang YL, Zhu ZY, et al. Biotransformation of triterpenoid ganoderic acids from exogenous diterpene dihydrotanshinone I in the cultures of Ganoderma sessile. Microbial Cell Factories. 2023;22:132
• Loyd AL, Richter BS, Jusino MA, et al. Identifying the “Mushroom of Immortality”: Assessing the Ganoderma species composition in commercial reishi products. Front Microbiol. 2018;9:1557
• Wu DT, Deng Y, Chen LX, et al. Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States. Sci Rep. 2017;7:7792
• Zhou LW, Cao Y, Wu SH, et al. Global diversity of the Ganoderma lucidum complex inferred from morphology and multilocus phylogeny. Phytochemistry. 2015;114:7-15
• Loyd AL, Barnes CW, Held BW, Schink MJ, Smith ME, Smith JA, Blanchette RA. Elucidating “lucidum”: Distinguishing the diverse laccate Ganoderma species of the United States. PLoS ONE. 2018;13(7):e0199738
• Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007;13:265-301
• Hapuarachchi KK, Wen TC, Deng CY, et al. Mycosphere essays 1: Taxonomic confusion in the Ganoderma lucidum species complex. Mycosphere. 2015;6(5):542-559

Connections

• Compare with Reishi (G. lucidum sensu lato) for the broader clinical evidence base; much of what applies to the genus likely extends to G. sessile but is unconfirmed
• Ganoderma tsugae (Hemlock Reishi) is the other major North American Ganoderma species, distinguished by its conifer host preference; both represent native alternatives to Asian lingzhi
• Ganoderma applanatum (Artist’s Conk) is a non-laccate North American Ganoderma species with distinct morphology and chemistry that can be confused with G. sessile by beginners
• The identification of G. sessile in commercial US reishi products (Loyd et al. 2018) highlights the critical importance of molecular authentication in the medicinal mushroom supplement industry
• Turkey Tail represents a complementary immunomodulatory species with stronger clinical evidence, commonly paired with Ganoderma species in integrative protocols
• The biotransformation study (Li et al. 2023) demonstrating conversion of Salvia miltiorrhiza diterpenes into ganoderic acid analogs by G. sessile cultures opens potential for novel compound discovery at the intersection of TCM herb and fungal pharmacology